drug

safinamide mesylate

Marketedupdated 2mo ago

by Zenara Pharma Pvt Ltd

Approved

community read0 votes

indications

investigational

Parkinson's Disease

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 3h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Jun 8, 2027

333 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

Mar 21, 2031method-of-use (U-1993)US 82833804.7y
Mar 21, 2031method-of-use (U-1993)US 82833804.7y
Dec 10, 2028compositionUS 80765152.4y
Dec 10, 2028compositionUS 80765152.4y
Jun 8, 2027compositionUS 8278485333d
Jun 8, 2027compositionUS 8278485333d